Peter Knapp
Urology · Carmel, INNPI 1013921709
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $6,250 of the $9,580 with a category attached, or 65.2%. Medtronic accounts for 70.1% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2021 at $6,270 and has fallen 97.6% since, to $147 in 2024.
Across 134 payments — averaging $71.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$7K
- Boston Scientific$461
- AbbVie$332
- Astellas Pharma US Inc$302
- Neotract Inc.$239
- Pfizer$210
- plus $1K from 25 others
What the payments were for
- Speaking & faculty fees$6,25065%
- Food & beverage$3,31535%
- Education$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 16 | $6,718 |
| Boston Scientific | 14 | $461 |
| AbbVie(2 entities) | 20 | $332 |
| Astellas Pharma US Inc | 15 | $302 |
| Neotract Inc. | 2 | $239 |
| Pfizer | 14 | $210 |
| Johnson & Johnson | 2 | $161 |
| Axonics, Inc. | 6 | $116 |
| Coloplast | 4 | $107 |
| Bayer | 5 | $91 |
| Tolmar Pharmaceuticals, Inc. | 1 | $89 |
| Myovant Sciences Inc. | 4 | $87 |
| Advanced Accelerator Applications | 1 | $85 |
| Dendreon Pharmaceuticals LLC | 2 | $68 |
| Urogen Pharma, Inc. | 2 | $59 |
| Amgen | 4 | $52 |
| Laborie Medical Technologies Corp. | 3 | $48 |
| Blue Earth Diagnostics | 2 | $47 |
| Abbott | 1 | $45 |
| Antares Pharma, Inc. | 3 | $42 |
| Merck | 2 | $29 |
| Tolmar, Inc. | 1 | $28 |
| Travere Therapeutics, Inc. | 2 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Progenics Pharmaceuticals, Inc. | 1 | $21 |
| Endo Pharmaceuticals Inc. | 1 | $20 |
| Telix Pharmaceuticals | 1 | $18 |
| Mallinckrodt Hospital Products Inc. | 1 | $16 |
| Cook Medical LLC | 1 | $16 |
| Foundation Medicine, Inc. | 1 | $15 |
| Mission Pharmacal Company | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,580 in reported general payments places this provider in the 70th percentile of 272 urology providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 64 | $77,848 |
| GemtesaVibegron | 40 | $38,201 |
| Mirabegron ErMirabegron | 11 | $11,550 |
| Tamsulosin Hcl | 359 | $6,782 |
| Trospium Chloride | 65 | $5,102 |
| Desmopressin Acetate | 21 | $2,220 |
| Oxybutynin Chloride ErOxybutynin Chloride | 99 | $2,199 |
| Solifenacin Succinate | 12 | $1,791 |
| Duloxetine Hcl | 79 | $1,533 |
| Bethanechol Chloride | 12 | $760 |
| NitrofurantoinNitrofurantoin Macrocrystal | 18 | $756 |
| Trimethoprim | 15 | $590 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 24 | $453 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 20 | $435 |
| Oxybutynin Chloride | 23 | $380 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $302 | $77,84864 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 272 urology providers in Indiana.
Other urology in Carmel
- Alexander TatemCarmel$418K
- Chad ReichardCarmel$400K
- Matthew MellonCarmel$159K
- Jason KovacCarmel$112K
- Kenneth NeyCarmel$55K
- Jeremiah DallmerCarmel$52K
- Scott FarnhamCarmel$30K
- Megan BockCarmel$28K
- Joshua RingCarmel$13K
- Clinton BahlerCarmel$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.